
POINTS OF VIEW10 April 2025
Is TraceLink a Sinking Ship?
A candid look at platform lock-in, pricing, and what mid-market pharma should weigh before committing.
Aqra →Perspettivi sinċieri dwar l-industrija tas-serjalizzazzjoni farmaċewtika — minn nies li jaħdmu fiha kuljum.

A candid look at platform lock-in, pricing, and what mid-market pharma should weigh before committing.
Aqra →
The uncomfortable truths about serialisation programmes that vendors would rather you didn't hear.
Aqra →
Honest conversations with the people who actually run serialisation operations day to day.
Aqra →